Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease

Gut microbiota and their metabolites in the progression of non-alcoholic fatty liver disease

10.20517/2394-5079.2020.134

Saved in:

Bibliographic Details
Main Authors:	Zhou, J, Tripathi, M, Sinha, RA, Singh, BK, Yen, PM
Other Authors:	DEAN'S OFFICE (DUKE-NUS MEDICAL SCHOOL)
Format:	Review
Published:	OAE Publishing Inc. 2022
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/226697
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Gut Microbiota and Non-Alcoholic Fatty Liver Disease: Current Pathogenic Paradigm and Therapeutic Aspect
by: Ummi Maimunah, Ummi, et al.
Published: (2023)

Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists
by: Sinha, Rohit A, et al.
Published: (2022)

Messengers from the gut: gut microbiota-derived metabolites on host regulation
by: Li, Chenyu, et al.
Published: (2022)

Gut-liver axis in nonalcoholic fatty liver disease (NAFLD)
by: Koo, Yolanda Wei Ling
Published: (2023)

MOLECULAR DISSECTION OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: NOOSHIN NOURBAKHSH
Published: (2023)

The role of gut microbiota in health and diseases
by: Deasy Fetarayani, et al.
Published: (2021)

Gut microbiota and hepatic PPARS in the regulation of liver circadian rhythm
by: Oh, Penny Hui Yun
Published: (2019)

The liver-gut microbiota axis modulates hepatotoxicity of tacrine in the rat
by: Yip, Lian Yee, et al.
Published: (2020)

Gut microbiota metabolite indole propionic acid targets tryptophan biosynthesis in Mycobacterium tuberculosis
by: Negatu, D.A., et al.
Published: (2022)

Gut Microbiota and Stroke
Published: (2020)

EXPLORING RECEPTOR TYROSINE KINASES IN THE MANAGEMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE
by: BHAVE SAYALI SHRIVARDHAN
Published: (2023)

Non-alcoholic fatty liver disease in women – Current knowledge and emerging concepts
by: Eng, PC, et al.
Published: (2023)

A pathophysiological model of non-alcoholic fatty liver disease using precision-cut liver slices
by: Grietje H. Prins, et al.
Published: (2020)

The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
by: Wasit Wongtrakul, et al.
Published: (2022)

Revisit gut microbiota and its impact on human health and disease
by: Ding, R.-X., et al.
Published: (2021)

How should we manage patients with non-alcoholic fatty liver disease in 2007?
by: Chan, H.L.-Y., et al.
Published: (2016)

The Effect of Diabetes and Prediabetes on the Prevalence, Complications and Mortality in Non-alcoholic Fatty Liver Disease.
by: Ng, Cheng Han, et al.
Published: (2022)

Diet, gut microbiota and cognition
by: Cicely Proctor, et al.
Published: (2018)

Diet, gut microbiota and cognition
by: Proctor C., et al.
Published: (2017)

Diet, gut microbiota and cognition
by: Cicely Proctor, et al.
Published: (2018)

Neurobehavioural consequences of the gut microbiota
by: Martin, Katherine
Published: (2021)

Whole-cell screen of fragment library identifies gut microbiota metabolite indole propionic acid as antitubercular
by: Negatu, D.A, et al.
Published: (2020)

Modelling non-alcoholic fatty liver disease using patient derived liver stem cells and hepatic organoids
by: Lim, Yee Siang
Published: (2020)

Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study
by: Eunice Xiang Xuan Tan, et al.
Published: (2022)

Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study.
by: Tan, Eunice Xiang-Xuan, et al.
Published: (2021)

Non-obese non-alcoholic fatty liver disease (NAFLD) in Asia: an international registry study
by: Tan E.X.X.
Published: (2023)

Bidirectional association between non-alcoholic fatty liver disease and fatty pancreas: a systematic review and meta-analysis
by: Wongtrakul W.
Published: (2023)

Weight Reduction and Pioglitazone are Cost-Effective for the Treatment of Non-Alcoholic Fatty Liver Disease in Thailand
by: Bunchai Chongmelaxme, et al.
Published: (2020)

Restoration of lysosomal acidification rescues autophagy and metabolic dysfunction in non-alcoholic fatty liver disease
by: Zeng, Jialiu, et al.
Published: (2023)

Exploring the Gamut of Receptor Tyrosine Kinases for Their Promise in the Management of Non-Alcoholic Fatty Liver Disease
by: Bhave, Sayali, et al.
Published: (2022)

Gamma-glutamyl transferase and cardiovascular risk in nonalcoholic fatty liver disease: The Gut and Obesity Asia initiative
by: Panyavee Pitisuttithum, et al.
Published: (2020)

Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
by: Giovanni Musso, et al.
Published: (2018)

The Gut Microbiota and Autism Spectrum Disorders
by: Li, Qinrui, et al.
Published: (2017)

Identification of patients with type 2 diabetes with non-alcoholic fatty liver disease who are at increased risk of progressing to advanced fibrosis: a cross-sectional study
by: Mettananda, Chamila, et al.
Published: (2023)

Peroxisome proliferator-activated receptors and their novel ligands as candidates for the treatment of non-alcoholic fatty liver disease
by: Fougerat, Anne, et al.
Published: (2020)

miRNA regulation of glucose and lipid metabolism in relation to diabetes and non-alcoholic fatty liver disease
by: Tanapa Suksangrat, et al.
Published: (2020)

Muscle strength, but not body mass index, is associated with mortality in patients with non-alcoholic fatty liver disease
by: Charatcharoenwitthaya P.
Published: (2023)

Second harmonic generation microscopy provides accurate automated staging of liver fibrosis in patients with non-alcoholic fatty liver disease
by: Chang P.E., et al.
Published: (2019)

Gut microbiota-generated metabolite, trimethylamine-N-oxide, and subclinical myocardial damage: a multicenter study from Thailand
by: Vichai Senthong, et al.
Published: (2022)

The gut microbiota and developmental programming of the testis in mice
by: Al-Asmakh, Maha, et al.
Published: (2014)